SARS-CoV-2: Has artificial intelligence stood the test of time.
10.1097/CM9.0000000000002058
- Author:
Mir Ibrahim SAJID
1
;
Shaheer AHMED
2
;
Usama WAQAR
1
;
Javeria TARIQ
1
;
Mohsin CHUNDRIGARH
1
;
Samira Shabbir BALOUCH
3
;
Sajid ABAIDULLAH
4
Author Information
1. Medical College, Aga Khan University, Stadium Road, Karachi, Pakistan.
2. Medlcal College, Islamabad Medical and Dental College, Main Murree Road, Islamabad, Pakistan.
3. Oral and Maxillofacial Surgery, King Edward Medical University, Neela Gumbad, Lahore, Pakistan.
4. King Edward Medical University, Neela Gumbad, Lahore, Pakistan.
- Publication Type:Journal Article
- MeSH:
Artificial Intelligence;
COVID-19;
Communicable Disease Control;
Humans;
Pandemics/prevention & control*;
SARS-CoV-2
- From:
Chinese Medical Journal
2022;135(15):1792-1802
- CountryChina
- Language:English
-
Abstract:
Artificial intelligence (AI) has proven time and time again to be a game-changer innovation in every walk of life, including medicine. Introduced by Dr. Gunn in 1976 to accurately diagnose acute abdominal pain and list potential differentials, AI has since come a long way. In particular, AI has been aiding in radiological diagnoses with good sensitivity and specificity by using machine learning algorithms. With the coronavirus disease 2019 pandemic, AI has proven to be more than just a tool to facilitate healthcare workers in decision making and limiting physician-patient contact during the pandemic. It has guided governments and key policymakers in formulating and implementing laws, such as lockdowns and travel restrictions, to curb the spread of this viral disease. This has been made possible by the use of social media to map severe acute respiratory syndrome coronavirus 2 hotspots, laying the basis of the "smart lockdown" strategy that has been adopted globally. However, these benefits might be accompanied with concerns regarding privacy and unconsented surveillance, necessitating authorities to develop sincere and ethical government-public relations.
